{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:34:48Z","timestamp":1772534088547,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Oncol.Rev."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Lymph node metastasis in vulvar cancer is a critical prognostic factor associated with higher recurrence and decreased survival. A survival benefit is reported with adjuvant radiotherapy but with potential significant morbidity. We aim to clarify whether there is high-quality evidence to support the use of adjuvant radiotherapy in this setting.<\/jats:p><jats:p><jats:bold>Objectives:<\/jats:bold> The aim of the study was to assess the effectiveness and safety of adjuvant radiotherapy to locoregional metastatic nodal areas.<\/jats:p><jats:p><jats:bold>Search Methods:<\/jats:bold> We conducted a comprehensive and systematic literature search of MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Google Scholar, <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>, and the National Cancer Institute. We considered only randomized controlled trials (RCTs).<\/jats:p><jats:p><jats:bold>Main Results:<\/jats:bold> We identified 1,760 records and finally retrieved only one eligible RCT (114 participants with positive inguinofemoral lymph nodes). All women had undergone radical vulvectomy and bilateral inguinal lymphadenectomy and had been randomized to adjuvant radiotherapy or to intraoperative ipsilateral pelvic lymphadenectomy without adjuvant radiotherapy. At 6\u00a0years, the overall survival (OS) was 51% versus 41% in favor of radiotherapy (HR 0.61; 95% CI 0.30\u20131.3) without significance and with very low certainty of evidence. At 6 year, the cumulative incidence of cancer-related deaths was 29% versus 51% in favor of adjuvant radiotherapy (HR 0.49; 95% CI 0.28\u20130.87). Recurrence-free survival at 6 years was 59% after adjuvant radiotherapy versus 48% after pelvic lymphadenectomy (HR 0.39; 95% CI 0.17\u20130.88). Three (5.3%) versus 13 (24.1%) groin recurrences were noted, respectively, in the adjuvant radiotherapy and pelvic lymphadenectomy groups. There was no significant difference in acute toxicities for pelvic lymphadenectomy compared to radiotherapy. In women with positive pelvic lymph nodes (20%), the OS at 6 year was 36% compared with 13% in favor of adjuvant radiotherapy. Late cutaneous toxicity rate appeared to be greater after radiotherapy (19% vs. 15%) but with less chronic lymphedema (16% vs. 22%).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> There is only very low-quality evidence on administering adjuvant radiotherapy for inguinal lymph node metastases. Although the identified study was a multicenter RCT, there was a reasonable imprecision and inconsistency because of small study numbers, wide confidence intervals in the data, and early trial closure, resulting in downgrading of the evidence.<\/jats:p>","DOI":"10.3389\/or.2024.1389035","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T14:03:53Z","timestamp":1715090633000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Adjuvant Radiotherapy for Groin Node Metastases Following Surgery for Vulvar Cancer: A Systematic Review"],"prefix":"10.3389","volume":"18","author":[{"given":"Federico","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamiese","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran","family":"Hardern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Gozzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooman","family":"Soleymani Majd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"B1","unstructured":"Vulvar Cancer Incidence Statistics2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ygyno.2015.03.013","article-title":"Prognostic Role of Inguinal Lymphadenectomy in Vulvar Squamous Carcinoma: Younger and Older Patients Should Be Equally Treated. A Prospective Study and Literature Review","volume":"137","author":"Panici","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"CD002224","DOI":"10.1002\/14651858.CD002224.pub2","article-title":"Primary Groin Irradiation Versus Primary Groin Surgery for Early Vulvar Cancer","volume":"2011","author":"Van Der Velden","year":"2011","journal-title":"Cochrane database Syst Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.ejso.2019.07.029","article-title":"Multivariate Analysis of Prognostic Factors in Primary Squamous Cell Vulvar Cancer: The Role of Perineural Invasion in Recurrence and Survival","volume":"45","author":"Ferrari","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/igc.0b013e31823eed4c","article-title":"Prognostic Role of Lymph Node Metastases in Vulvar Cancer and Implications for Adjuvant Treatment","volume":"22","author":"Woelber","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","article-title":"Role of Tumour-Free Margin Distance for Loco-Regional Control in Vulvar Cancer-A Subset Analysis of the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie CaRE-1 Multicenter Study","volume":"69","author":"Woelber","year":"2016","journal-title":"Eur J Cancer"},{"key":"B7","first-page":"272","volume-title":"Christian Wittekind. TNM Classification of Malignant Tumours","author":"Brierley","year":"2016"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer - Update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B9","first-page":"117","article-title":"Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume-title":"J Natl Compr Canc Netw","author":"Abu-Rustum","year":"2024"},{"key":"B10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ygyno.2004.08.015","article-title":"Patterns of Recurrence and Disease-Free Survival in Advanced Squamous Cell Carcinoma of the Vulva","volume":"95","author":"Lataifeh","year":"2004","journal-title":"Gynecol Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2354.2008.01011.x","article-title":"Groin Recurrence in Carcinoma of the Vulva: Management and Outcome","volume":"19","author":"Cormio","year":"2010","journal-title":"Eur J Cancer Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1006\/gyno.2001.6180","article-title":"Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study","volume":"81","author":"Wagenaar","year":"2001","journal-title":"Gynecol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.3390\/cancers13225747","article-title":"The Radiotherapy Role in the Multidisciplinary Management of Locally Advanced Vulvar Cancer: A Multidisciplinary VulCan Team Review","volume":"13","author":"Tagliaferri","year":"2021","journal-title":"Cancers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijrobp.2016.09.023","article-title":"Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base","volume":"97","author":"Chapman","year":"2017","journal-title":"Int J Radiat Oncology Biology Physics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ejso.2019.07.005","article-title":"Surgical Treatment of Vulvar Cancer: Impact of Tumor-Free Margin Distance on Recurrence and Survival. A Multicentre Cohort Analysis From the Francogyn Study Group","volume":"45","author":"Raimond","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ygyno.2013.12.022","article-title":"An Analysis of Reported Independent Prognostic Factors for Survival in Squamous Cell Carcinoma of the Vulva: Is Tumor Size Significance Being Underrated?","volume":"132","author":"Aragona","year":"2014","journal-title":"Gynecol Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/IGC.0000000000000125","article-title":"Lymph Node Count at Inguinofemoral Lymphadenectomy and Groin Recurrences in Vulvar Cancer","volume":"24","author":"van Beekhuizen","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0360-3016(97)82500-x","article-title":"Adjuvant Radiation for Vulvar Carcinoma:Improved Local Control","volume":"38","author":"Faul","year":"1997","journal-title":"Int J Radiat Oncology Biology Physics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/1097-0142(19941101)74:9<2491::aid-cncr2820740916>3.0.co;2-5","article-title":"Prognostic Significance of Lymph Node Variables in Squamous Cell Carcinoma of the Vulva","volume":"74","author":"Paladini","year":"1994","journal-title":"Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0090-8258(89)90157-1","article-title":"Concurrent Radiation and Chemotherapy in Vulvar Carcinoma","volume":"34","author":"Thomas","year":"1989","journal-title":"Gynecol Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1245\/s10434-016-5114-6","article-title":"The Risk of Contralateral Non-Sentinel Metastasis in Patients With Primary Vulvar Cancer and Unilaterally Positive Sentinel Node","volume":"23","author":"Woelber","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1200\/JCO.21.00006","article-title":"Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II","volume":"39","author":"Oonk","year":"2021","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/0284186x.2019.1687934","article-title":"Inguino-Femoral Radiotherapy in Vulvar Squamous Cell Carcinoma: Clues to Revised Indications in Patients With Only One Intracapsular Lymph Node Metastasis","volume":"59","author":"Serre","year":"2020","journal-title":"Acta Oncologica"},{"key":"B24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ygyno.2015.03.056","article-title":"Impact of Adjuvant Chemotherapy With Radiation for Node-Positive Vulvar Cancer: A National Cancer Data Base (NCDB) Analysis","volume":"137","author":"Gill","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ygyno.2006.06.030","article-title":"The Benefit of Adjuvant Radiation Therapy in Single-Node-Positive Squamous Cell Vulvar Carcinoma","volume":"103","author":"Parthasarathy","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2021.11.004","article-title":"Adjuvant Radiotherapy and Local Recurrence in Vulvar Cancer \u2013 A Subset Analysis of the AGO-CaRE-1 Study","volume":"164","author":"Woelber","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B28","article-title":"Chapter 7: Selecting Studies and Collecting Data","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"B29","article-title":"Assessing Risk of Bias in Included Studies","volume-title":"In Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2024"},{"key":"B30","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/aog.0b013e3181b12f99","article-title":"Radiation Therapy Compared With Pelvic Node Resection for Node-Positive Vulvar Cancer: A Randomized Controlled Trial","volume":"114","author":"Kunos","year":"2009","journal-title":"Obstet Gynecol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-Bias VISualization (Robvis): An R Package and Shiny Web App for Visualizing Risk-Of-Bias Assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"B33","volume-title":"GRADEpro Guideline Development Tool [Software]","year":"2024"},{"key":"B34","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.radonc.2018.03.023","article-title":"Role of Adjuvant External Beam Radiotherapy and Chemotherapy in One Versus Two or More Node-Positive Vulvar Cancer: A National Cancer Database Study","volume":"129","author":"Rydzewski","year":"2018","journal-title":"Radiother Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"dju426","DOI":"10.1093\/jnci\/dju426","article-title":"Adjuvant Therapy in Lymph Node-Positive Vulvar Cancer: The AGO-CaRE-1 Study","volume":"107","author":"Mahner","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ygyno.2020.10.023","article-title":"GOG 244 - The Lymphedema and Gynecologic Cancer (LeG) Study: The Impact of Lower-Extremity Lymphedema on Quality of Life, Psychological Adjustment, Physical Disability, and Function","volume":"160","author":"Carter","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12905-023-02522-w","article-title":"Prognostic Value of Postoperative Radiotherapy in Patients with Vulvar Squamous Carcinoma: Findings Based on the SEER Database","volume":"23","author":"Li","year":"2023","journal-title":"BMC Women\u2019s Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2022.09.009","article-title":"The Role of Adjuvant Radiation Therapy in Older Patients With Node-Positive Vulvar Cancer: A National Cancer Database Analysis","volume":"167","author":"Ni","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ygyno.2023.07.013","article-title":"Vulvar Cancer Survival by Primary Treatment Modality: A Retrospective Cohort Study","volume":"176","author":"Bruce","year":"2023","journal-title":"Gynecol Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ygyno.2020.10.008","article-title":"Radiotherapy Is Not Indicated in Patients With Vulvar Squamous Cell Carcinoma and Only One Occult Intracapsular Groin Node Metastasis","volume":"160","author":"Van Der Velden","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1136\/ijgc-2022-004122","article-title":"Phase II Activity Trial of High-Dose Radiation and Chemosensitization in Patients With Macrometastatic Lymph Node Spread After sentinel Node Biopsy in Vulvar Cancer: GROningen INternational Study on Sentinel Nodes in Vulvar Cancer III (GROINSS-V III\/NRG-GY024)","volume":"33","author":"Gien","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/cmar.s143316","article-title":"Vulvar Carcinoma: Dilemma, Debates, and Decisions","volume":"10","author":"Mitra","year":"2018","journal-title":"Cancer Manage Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ygyno.2017.05.004","article-title":"Challenges to Delivery and Effectiveness of Adjuvant Radiation Therapy in Elderly Patients With Node-Positive Vulvar Cancer","volume":"146","author":"Swanick","year":"2017","journal-title":"Gynecol Oncol"}],"container-title":["Oncology Reviews"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2024.1389035\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T14:04:05Z","timestamp":1715090645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2024.1389035\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":43,"alternative-id":["10.3389\/or.2024.1389035"],"URL":"https:\/\/doi.org\/10.3389\/or.2024.1389035","relation":{},"ISSN":["1970-5557"],"issn-type":[{"value":"1970-5557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"article-number":"1389035"}}